Lindsay McNair

Dr. Lindsay McNair is the Chief Clinical Research Officer and President, Consulting Services for the WIRB- Copernicus Group. In this role, Dr. McNair develops strategic partnerships with pharma/biotech companies for comprehensive ethical and clinical services. She oversees a consulting group which and provides consultation on HRPP assessment and transformation, ethical trial design, protocol development, data request review and data transparency guidance, and the development of ethical clinical research policy and practices. Dr. McNair has more than 15 years of experience in clinical research and drug development strategy. She has designed and provided medical monitoring for Phase 1-4 clinical studies in a variety of therapeutic areas, including multiple oncology indications, hepatitis C, multiple inflammation indications (psoriasis, multiple sclerosis) and other areas.

Dr. McNair is an adjunct Assistant Professor at Boston University and teaches in the School of Public Health and in the Master’s of Clinical Investigation graduate programs, on the design and conduct of clinical research studies. Dr. McNair speaks frequently on the ethical conduct of clinical research studies as part of pharmaceutical drug development, and improving interactions between ethics committees/ research review boards and the pharmaceutical industry.

Dr. McNair graduated from the University Of Connecticut School Of Medicine and trained in general surgery at Boston University Medical Center. She has a Master’s in Public Health (Biostatistics/Epidemiology and Health Policy), and a Master’s of Science in Bioethics (research ethics). She was a member of the Institutional Review Board at Boston University Medical Center, and founded the Human Subject Protection Committee at Vertex Pharmaceuticals. She is a member of PRIM&R (a national research ethics association), and was a site visitor for the Association for the Accreditation of Human Research Protection Programs (AAHRPP).